期刊文献+

胆脂瘤上皮细胞增殖与凋亡的基因调控

原文传递
导出
摘要 中耳胆脂瘤上皮具有异常增殖的能力,在某些基因、蛋白、细胞因子的调控下,其凋亡能力亦显著增强。先后有多种基因被发现在胆脂瘤上皮中存在异常表达,其中既有促进细胞增殖的基因,如c—myc、c-jun、Ras;也有促进细胞凋亡的基因,如Erb-2、p53、p27。本文就近年来胆脂瘤上皮增殖与凋亡的基因调控研究进展进行综述。
作者 曾薇 郑亿庆
出处 《国际耳鼻咽喉头颈外科杂志》 2008年第3期128-130,共3页 International Journal of Otolaryngology-Head and Neck Surgery
关键词 胆脂瘤 细胞增殖 细胞凋亡 Cholesteatoma Cell Proliferation Apoptosis
  • 相关文献

参考文献20

  • 1Olszewska E, Chodynicki S, Chyczewski L, et al. Some markers of proliferative activity in cholesteatoma epithelium in adults.Med SciMonit, 2006, 12 (8) .- CR337-340.
  • 2Sudhoff L, Bujia J, Fisseler-EckhoffA, et al. Expression of a cell-cycle-associated nuclear antigen (MIB 1 ) in cholesteatoma and auditory meatal skin. Laryngoscope, 1995, 105 (11) : 1227-1231.
  • 3Tanaka Y, Shiwa M, Kojima H, et al. A study on epidermal proliferation ability in cholesteatoma. Laryngoscope, 1998, 108 (N4Pt1) : 537-342.
  • 4Mallet Y, Nouwen J, Lecomte-Houcke M, et al. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1. Laryngoscope, 2003, 113 (2) : 328-331.
  • 5Kojima H, Tanaka Y, Tanaka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg, 1998, 124 (3) : 261-264.
  • 6Olszewska E, Chodynicki S, Chyczewski L. Apoptosis in the pathogenesis of cholesteatoma in adults. Eur Arch Otorhinolaryngol, 2006, 263 (5): 409-413.
  • 7Watabe-RudolphM, Rudolph KL, AverbeckT, etal. Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma. Otol Neurotol, 2002, 23 (5) : 793-798.
  • 8Lee SH, Jang YH, Tae K, et al. Telomerase activity and cell proliferation index in cholesteatoma. Acta Otolaryngol, 2005, 125 (7) : 707-712.
  • 9Ozturk K, Yildirim MS, Acar H, et al. Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique. Otol Neurotol, 2006, 27 (5) : 588-591.
  • 10张凤英,刘敬波,苑铁军,刘清明,韩在文,王树勇,张传毅,陈淑萍.端粒酶催化亚单位和c-Myc蛋白在中耳胆脂瘤上皮中的表达及意义[J].临床耳鼻咽喉科杂志,2005,19(7):302-304. 被引量:2

二级参考文献10

  • 1曹文庆,中华皮肤科杂志,1996年,29卷,85页
  • 2Goh E K,Lee B J, Byung J,et al. Expression of telomerase activity in cholesteatoma otitis media. J Laryngol Otol,2001,115:881 -884.
  • 3Holly A, Sittinger M, Bujia J. Immunohistochemical detection of c-Myc proto-oncogene products in middle ear cholesteatoma. Laryngorhinootologie, 1995,74:348-351.
  • 4Rubin H. Telomerase and cellular lifespan: ending the debate? Nat Biotechol, 1998,16:396-397.
  • 5Nakamura M,Morin G B,Chapman K B,et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997,277: 955- 959.
  • 6Kyo S, Takakura M, Inoue M. Telomerase activity in cancer as a diagnostic and therapeutic target. Histol Histopathol,2000,15: 813-824.
  • 7Ransone L,Verma I.Nuclear proto-oncogenes fos and jun[J].Ann Rev Cell Biol,1990,6:539-550.
  • 8Angel P,Karin M.The role of jun,fos and AP-1 complex in cell-proliferation and transformation[J].Biochimica Biophysica Acta,1991,1072:129-141.
  • 9Shinoda H,Huang CC.Expression of c-jun and p53 proteins in human middle ear cholesteatoma:relationship to kerationocyte proliferation differatiation,and programmed cell death[J].Laryngoscope,1995,105:1231-1237.
  • 10Cowley S,Paterson H,Kemp P,et al.Activation of MAPK kinases is necessary and sufficient for PC21 differentiation and for transformation of NIH/3T3 cells[J].Cell,1994,77:841-852.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部